Peter Zill

Munich, BY 80336, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Validation of GDAP1 and HECW2 as Epigenetic Markers of Alcohol Use Disorder in Blood and Brain.

Validation of GDAP1 and HECW2 as Epigenetic Markers of Alcohol Use Disorder in Blood and Brain.

Journal: International journal of molecular sciences

Published: October 05, 2025

Genome-wide association study of borderline personality disorder identifies 11 loci and highlights shared risk with mental and somatic disorders.

Genome-wide association study of borderline personality disorder identifies 11 loci and highlights shared risk with mental and somatic disorders.

Journal: medRxiv : the preprint server for health sciences

Published: August 20, 2025

Genome-wide association analyses of borderline personality disorder identify 11 loci and highlight shared risk with mental and somatic disorders.

Genome-wide association analyses of borderline personality disorder identify 11 loci and highlight shared risk with mental and somatic disorders.

Journal: Nature genetics

Published: November 21, 2024

Association of clinical parameters and polygenic risk scores for body mass index, schizophrenia, and diabetes with antipsychotic-induced weight gain.

Association of clinical parameters and polygenic risk scores for body mass index, schizophrenia, and diabetes with antipsychotic-induced weight gain.

Journal: Journal of psychiatric research

Published: July 04, 2023

The Interplay of Oxytocin and Attachment in Schizophrenic Patients: An fMRI Study.

The Interplay of Oxytocin and Attachment in Schizophrenic Patients: An fMRI Study.

Journal: Brain sciences

Published: June 03, 2023

The multimodal Munich Clinical Deep Phenotyping study to bridge the translational gap in severe mental illness treatment research.

The multimodal Munich Clinical Deep Phenotyping study to bridge the translational gap in severe mental illness treatment research.

Journal: Frontiers in psychiatry

Published: March 04, 2023

Prospective DNA Methylation Analysis of the CpG GABRA2 Receptor Subunit in Alcohol Dependence during Detoxification.

Prospective DNA Methylation Analysis of the CpG GABRA2 Receptor Subunit in Alcohol Dependence during Detoxification.

Journal: Medicina (Kaunas, Lithuania)

Published: September 13, 2022

Biobanking in everyday clinical practice in psychiatry-The Munich Mental Health Biobank.

Biobanking in everyday clinical practice in psychiatry-The Munich Mental Health Biobank.

Journal: Frontiers in psychiatry

Published: May 02, 2022

Examining the synergistic effects of a cognitive control video game and a home-based, self-administered non-invasive brain stimulation on alleviating depression: the DiSCoVeR trial protocol.

Examining the synergistic effects of a cognitive control video game and a home-based, self-administered non-invasive brain stimulation on alleviating depression: the DiSCoVeR trial protocol.

Journal: European archives of psychiatry and clinical neuroscience

Published: March 01, 2022

Role of psychiatric hospitals during a pandemic: introducing the Munich Psychiatric COVID-19 Pandemic Contingency Plan.

Role of psychiatric hospitals during a pandemic: introducing the Munich Psychiatric COVID-19 Pandemic Contingency Plan.

Journal: BJPsych open

Published: February 01, 2021

Editorial: Developmental Abnormalities of Serotonin Homeostasis in Behavioral and Metabolic Disorders: From Epigenetic Mechanisms to Protein Function.

Editorial: Developmental Abnormalities of Serotonin Homeostasis in Behavioral and Metabolic Disorders: From Epigenetic Mechanisms to Protein Function.

Journal: Frontiers in neuroscience

Published: January 27, 2021

Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder: Macrophage Migration Inhibitory Factor as a Promising Biomarker for Remission After Sertraline-Results From a Randomized Controlled Clinical Trial.

Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder: Macrophage Migration Inhibitory Factor as a Promising Biomarker for Remission After Sertraline-Results From a Randomized Controlled Clinical Trial.

Journal: Frontiers in psychiatry

Published: October 08, 2020

Showing 1-12 of 66

Last Updated: 09/26/2026